These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2362189)
1. In-vitro susceptibility of clinical isolates of Serratia species to antimicrobial agents. Sofianou D; Proya E; Kondodimou A J Chemother; 1990 Apr; 2(2):79-81. PubMed ID: 2362189 [TBL] [Abstract][Full Text] [Related]
2. Synergistic interactions of ciprofloxacin and extended spectrum beta-lactams or aminoglycosides against Acinetobacter calcoaceticus ss. anitratus. Chow AW; Wong J; Bartlett KH Diagn Microbiol Infect Dis; 1988 Apr; 9(4):213-7. PubMed ID: 3180706 [TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa. Sofianou DC; Douboyas JP J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252 [TBL] [Abstract][Full Text] [Related]
4. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions. Giamarellou H Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998 [TBL] [Abstract][Full Text] [Related]
5. Natural antibiotic susceptibility of strains of Serratia marcescens and the S. liquefaciens complex: S. liquefaciens sensu stricto, S. proteamaculans and S. grimesii. Stock I; Grueger T; Wiedemann B Int J Antimicrob Agents; 2003 Jul; 22(1):35-47. PubMed ID: 12842326 [TBL] [Abstract][Full Text] [Related]
6. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital]. Ronco E; Vacheron F; Orabona A Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708 [TBL] [Abstract][Full Text] [Related]
7. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens. Langstaff D; Schueler S; Righter J J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa. Vurma-Rapp U; Kayser FH Eur J Clin Microbiol; 1986 Jun; 5(3):292-6. PubMed ID: 3091365 [TBL] [Abstract][Full Text] [Related]
9. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000). Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958 [TBL] [Abstract][Full Text] [Related]
10. Comparative susceptibilities of clinical isolates of Serratia marcescens to newer cephalosporins, alone and in combination with various aminoglycosides. Markowitz SM; Sibilla DJ Antimicrob Agents Chemother; 1980 Nov; 18(5):651-5. PubMed ID: 7004344 [TBL] [Abstract][Full Text] [Related]
11. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343. Medeiros AA; Hare R; Papa E; Adam C; Miller GH J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602 [TBL] [Abstract][Full Text] [Related]
12. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa. Meyer RD; Liu S Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii. Shi ZY; Liu PY; Lau Y; Lin Y; Hu BS; Shir J-M Diagn Microbiol Infect Dis; 1996 Feb; 24(2):81-5. PubMed ID: 9147913 [TBL] [Abstract][Full Text] [Related]
15. Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations. Chow AW; Wong J; Bartlett KH; Shafran SD; Stiver HG Antimicrob Agents Chemother; 1989 Aug; 33(8):1368-72. PubMed ID: 2508546 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa. Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group. Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863 [TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides. Watanakunakorn C; Kauffman CA Infection; 1978; 6(3):111-5. PubMed ID: 98451 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility to new beta-lactams of enterobacterial extended-spectrum beta-lactamase (ESBL) producers and penicillin-resistant Streptococcus pneumoniae in Mexico. Silva J; Aguilar C; Estrada MA; Echániz G; Carnalla N; Soto A; López-Antuñano FJ J Chemother; 1998 Apr; 10(2):102-7. PubMed ID: 9603634 [TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics. Weinstein RA; Nathan C; Delzell D; Kabins SA Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]